SPEXIS AG SF0,02SPEXIS AG SF0,02SPEXIS AG SF0,02

SPEXIS AG SF0,02

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪2.19 M‬EUR
−0.398EUR
‪−21.11 M‬EUR
‪65.90 M‬
Beta (1Y)
−0.19

About SPEXIS N

CEO
Jeffrey D. Wager
Headquarters
Allschwil
Founded
1996
ISIN
CH0106213793
FIGI
BBG00KW47PY1
Spexis Ltd. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of respiratory therapeutics. The firm focuses on rare, chronic respiratory diseases (CRD) and chronic lung infections in cystic fibrosis. Its product pipeline includes ColiFin, Inhaled Murepavadin, Balixafortide (POL6326), OMPTA, EBX-002, and POL6014 (Lonodelestat). The company was founded by Daniel Obrecht and Jean-Pierre Obrecht in 1996 and is headquartered in Allschwil, Switzerland.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on BER exchange SPEXIS AG SF0,02 stocks are traded under the ticker 29Y.
29Y reached its all-time high on Oct 4, 2018 with the price of 30.260 EUR, and its all-time low was 8.270 EUR and was reached on Jun 27, 2019. View more price dynamics on 29Y chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track SPEXIS AG SF0,02 financials in yearly and quarterly reports right on TradingView.
SPEXIS AG SF0,02 is going to release the next earnings report on Sep 5, 2024. Keep track of upcoming events with our Earnings Calendar.
29Y net income for the last half-year is ‪−16.91 M‬ EUR, while the previous report showed ‪−4.00 M‬ EUR of net income which accounts for −322.42% change. Track more SPEXIS AG SF0,02 financial stats to get the full picture.
No, 29Y doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 29Y shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SPEXIS AG SF0,02 stock right from TradingView charts — choose your broker and connect to your account.